Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.
The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 79 companies including many key and niche players such as
- Affymetrix, Inc. (US)
- Agilent Technologies, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid Inc. (US)
- Fluidigm Corporation (US)
- GE Healthcare Ltd. (UK)
- Hoffman-La-Roche Ltd. (Switzerland)
- Illumina, Inc. (US)
- Ocimum Biosolutions Ltd. (India)
- PerkinElmer, Inc. (US)
- Takara Bio, Inc. (Japan)
- Clontech Laboratories, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
3. COMPETITION
4. PRODUCT OVERVIEW
5. BIOCHIP AND MICROARRAY CONSTRUCTION
6. APPLICATIONS OF BIOCHIPS
7. PRODUCT INTRODUCTIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79 (including Divisions/Subsidiaries 86)
- The United States (45)
- Canada (2)
- Japan (6)
- Europe (22)
- - France (2)
- - Germany (6)
- - The United Kingdom (3)
- - Spain (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/wh78nb/biochips_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
John Ternus Signals Apple’s Future with Product-First AI Strategy
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 



